73 filings
10-Q
2024 Q1
AVTE
Aerovate Therapeutics Inc
Quarterly report
13 May 24
4:57pm
8-K
AVTE
Aerovate Therapeutics Inc
13 May 24
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
4:39pm
ARS
2023 FY
AVTE
Aerovate Therapeutics Inc
26 Apr 24
Annual report to shareholders
5:23pm
DEFA14A
AVTE
Aerovate Therapeutics Inc
26 Apr 24
Additional proxy soliciting materials
7:19am
DEF 14A
AVTE
Aerovate Therapeutics Inc
Definitive proxy
26 Apr 24
7:18am
8-K
fxhz82
27 Mar 24
Regulation FD Disclosure
9:22am
8-K
1564alpz3txav r4
25 Mar 24
Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights
4:12pm
S-8
65yxpl bmhwp
8 Jan 24
Registration of securities for employees
5:11pm
8-K
sfhblqjrnljp0a
8 Jan 24
Regulation FD Disclosure
7:59am
8-K
ffhre3g
20 Nov 23
Topline Phase 2b data expected in June 2024
4:46pm
8-K
rbkexa
13 Nov 23
Aerovate Therapeutics Announces Third Quarter Financial Results and Business Highlights
8:03am
8-K
l4rn1khemkzdd740i
14 Aug 23
Aerovate Therapeutics Announces Second Quarter Financial Results and Business Highlights
8:10am
8-K
4g960
11 Jul 23
Aerovate Therapeutics Appoints Habib Dable To Its Board of Directors
5:03pm
8-K
33omle t5
21 Jun 23
Other Events
5:14pm
8-K
8ho26nv2g
8 Jun 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
ckxcjt0bhmhv ma
15 May 23
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
4:08pm